Thorsen A B, Yung N S, Leung A C
Haven of Hope Hospital, Kowloon, Hong Kong.
Ann Acad Med Singap. 1994 Mar;23(2):209-11.
A retrospective study was carried out in 100 adult patients with advanced malignant disease. They were given subcutaneous continuous infusions of medication for symptom relief. The drugs were administered through a butterfly needle inserted subcutaneously in the anterior chest wall using a battery-operated infusion pump. The indications for using this technique were inability to swallow due to deteriorating general condition, oesophageal obstruction, intestinal obstruction, severe nausea and vomiting, terminal dyspnoea and poor pain control with oral opiates. All patients received morphine; other drugs administered through the syringe driver included hyoscine, metoclopramide, cyclizine, dexamethasone and midazolam. Ninety-four patients continued subcutaneous infusion until death. The mean duration of treatment was 9.1 days. The treatment was well tolerated by the patients and controlled their symptoms satisfactorily in the great majority. The use of continuous subcutaneous infusion via a syringe driver gives good symptom control. In the last days of life when the patients have difficulty tolerating oral medication, continuous subcutaneous infusion is a superior alternative to frequent intermittent parenteral injections.
对100例晚期恶性疾病成年患者进行了一项回顾性研究。他们接受皮下持续输注药物以缓解症状。药物通过使用电池驱动的输液泵经皮下插入前胸壁的蝶形针给药。使用该技术的指征包括因全身状况恶化而无法吞咽、食管梗阻、肠梗阻、严重恶心和呕吐、终末期呼吸困难以及口服阿片类药物疼痛控制不佳。所有患者均接受吗啡治疗;通过注射器驱动泵给药的其他药物包括东莨菪碱、甲氧氯普胺、赛克利嗪、地塞米松和咪达唑仑。94例患者持续皮下输注直至死亡。平均治疗持续时间为9.1天。患者对该治疗耐受性良好,且在绝大多数情况下能令人满意地控制症状。通过注射器驱动泵进行持续皮下输注能很好地控制症状。在生命的最后几天,当患者难以耐受口服药物时,持续皮下输注是频繁间歇性胃肠外注射的更佳选择。